Picture of Eurofins Scientific SE logo

ERF — Eurofins Scientific SE News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Bernstein starts Eurofins at 'market-perform'

** Bernstein initiates Eurofins Scientific  EUFI.PA  with a
"market-perform" rating, citing the ongoing saga with Muddy
Waters after the short-seller questioned the French lab testing
firm's financial statements
    ** "Lack of transparency damages what was meant to be a good
year," Bernstein says, but is more upbeat about future prospects
    ** "In our view, the current weak valuation stems solely
from the MW allegations and does not reflect future operations,"
it says
    ** Eurofins has nonetheless underperformed the commercial &
professional services and healthcare equipment sectors, with
investors worried about its margins in 2024, it adds
    ** "We see further margin upside in the US that investors
seem to be overlooking right now" - Bernstein 
    ** It sets a PT of 52.8 euros; Eurofins currently trades at
around 48.9 euros
    ** Out of 16 analysts that cover Eurofins, six rate the
stock "strong buy" or "buy",​ five "hold", and five​ "strong
sell" or "sell"

 (Reporting by Olivier Sorgho)
 ((Olivier.Sorgho@thomsonreuters.com))

Recent news on Eurofins Scientific SE

See all news